VIRICA
LIVE

Serial Number

98429871

Owner

Virica Biotech Inc.

Attorney

Nicole K. McLaughlin

Filing Date

Mar 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VIRICA Trademark

Serial Number: 98429871

VIRICA is a trademark filed by Virica Biotech Inc. on March 1, 2024. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Virica Biotech Inc. (3 trademarks)

7 Bayview Station Road
Ottawa, Ontario K1Y2C5 , CA

Entity Type: 03

Trademark Details

Filing Date

March 1, 2024

Registration Date

Not Registered

Goods & Services

Biological production, namely, custom manufacture of biological preparations in the field of gene therapy and cell therapies; biological production, namely, custom manufacture of biological preparations in the field of vaccines

Scientific research and analysis for scientific research purposes in the field of gene and cell therapies; scientific research and analysis for scientific research purposes in the field of vaccines; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields

Cell culture reagents for laboratory use, namely, for research use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; catalysts in the nature of small molecules for use in increasing viral yield for use in the manufacture of vaccines and viral medicines; chemical and biochemical preparations for scientific use, research use, and laboratory research use; chemical and biochemical preparations for scientific use and for scientific research use; reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses, and pseudo-viral particles; chemical and biochemical preparations, agents, and reagents sold as a unit for producing viruses using transfection for scientific use and for scientific research use

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 3, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 3, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 3, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 3, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 3, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 3, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 3, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 2, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 10, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 10, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 10, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 13, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 13, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 13, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2024 NWOS
NEW APPLICATION ENTERED
Mar 1, 2024 NWAP